BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38297922)

  • 21. The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
    Mordon S; Vignion-Dewalle AS; Abi-Rached H; Thecua E; Lecomte F; Vicentini C; Deleporte P; Béhal H; Kerob D; Hommel T; Duhamel A; Szeimies RM; Mortier L
    Br J Dermatol; 2020 Jan; 182(1):76-84. PubMed ID: 31021404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy: current evidence and applications in dermatology.
    Lee Y; Baron ED
    Semin Cutan Med Surg; 2011 Dec; 30(4):199-209. PubMed ID: 22123417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
    Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
    Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
    Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
    Fernández-Guarino M; Mavura D; Fernández-González P; Chapa P; Ravazzano C; Jaén L; Rios L; Jaén P; Grossman H
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101631. PubMed ID: 31904551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on photodynamic treatment for actinic keratosis.
    Wiegell SR
    Curr Probl Dermatol; 2015; 46():122-8. PubMed ID: 25561216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
    Galimberti GN
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
    Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
    BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
    O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
    JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
    Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential Treatment of Actinic Keratosis and Photoaging by Daylight PDT and Injectable NASHA Gel as Skin Booster.
    Belmontesi M
    J Drugs Dermatol; 2020 Nov; 19(11):1065-1068. PubMed ID: 33196754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source.
    Creusot M; Mordon S
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102618. PubMed ID: 34743007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daylight photodynamic therapy: experience in the treatment of actinic keratosis in the San Gallicano Institute (Rome) and a review of literature.
    Carbone A; Sperduti I; De Simone P; Piemonte P; Ferrari A; Buccini P; Silipo V; Iorio A; Frascione P; Eibenschutz L
    G Ital Dermatol Venereol; 2020 Jun; 155(3):312-319. PubMed ID: 29368865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
    Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
    Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
    Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
    Morton CA; Szeimies RM; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.